EUVIMEDEUVIMED entdecken
Crossref

Staphylococcal γ‐Hemolysin AB and γ‐Hemolysin CB Differentially Activate Murine Bone Marrow‐Derived Mast Cells

Hikaru Inoue, Haruka Sakakibara, Shion Kamada, Ayana Ogata, Kazuhito Hayashi, Shigeaki Hida iD, Saotomo Itoh iD

Genes to Cells · 2025

DOI: 10.1111/gtc.70047 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes to Cells, 2025. Verfasst von Hikaru Inoue und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cellular Health Sciences, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Japan. Hauptthemen laut MEDLINE: Hemolysin Proteins, Mast Cells, Bacterial Toxins, Bone Marrow Cells. Die Arbeit nennt 22 Literaturangaben. Gefördert von: Kobayashi Foundation, KOSÉ Cosmetology Research Foundation, Koyanagi Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Staphylococcus aureus ( S. aureus ) produces various bicomponent pore‐forming toxins (PFTs), including the γ‐hemolysins (HlgAB and HlgCB) and leukocidins (LukAB and LukED). This study aimed to examine the effect of PFTs on murine bone marrow‐derived mast cells (BMMCs). All the PFTs assessed in this study (HlgAB, HlgCB, LukAB, and LukED) were found to bind to BMMCs. Specifically, HlgAB and LukED, but not HlgCB or LukAB, induced membrane damage. Furthermore, only HlgAB induced BMMC degranulation, whereas HlgAB and HlgCB significantly augmented the degranulation caused by ionophore, immunocomplex, and staphylococcal δ‐toxin. The augmentation of degranulation by HlgAB was impaired when a pore‐formation defect mutant of HlgB (HlgBΔstem) was used. Conversely, the augmentation by HlgCB was unaffected following the use of HlgBΔstem, suggesting that HlgAB but not HlgCB augments degranulation in a pore‐formation‐dependent manner. These results highlight the novel roles for the staphylococcal γ‐hemolysins HlgAB and HlgCB, as they differentially affect the degranulation of mast cells in the effector phase of allergic inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemolysin ProteinsMast CellsBacterial ToxinsBone Marrow CellsBacterial ProteinsAnimalsMiceCell DegranulationStaphylococcus aureusCells, Cultured

Stichwörter der Autor:innen

degranulationmast cellsstaphylococcal γ‐hemolysins

Substanzen

Hemolysin ProteinsBacterial ToxinsBacterial Proteinsgamma-hemolysin, Staphylococcus aureus

Autor:innen und Institutionen

  • Department of Molecular and Cellular Health Sciences, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Japan.
  • Laboratory of Hygienic Chemistry, School of Pharmacy, Aichigakuin University, Nagoya, Japan.

ORCID-Profile: Shigeaki Hida, Saotomo Itoh

Förderung

  • Kobayashi Foundation
  • KOSÉ Cosmetology Research Foundation
  • Koyanagi Foundation
  • SENSHIN Medical Research Foundation
  • Takeda Science Foundation
  • Institute of Drug Discovery Science, Nagoya City University
  • Japan Society for the Promotion of Science

Zitieren

APA

Inoue, H., Sakakibara, H., Kamada, S., Ogata, A., Hayashi, K., Hida, S., & Itoh, S. (2025). Staphylococcal γ‐Hemolysin AB and γ‐Hemolysin CB Differentially Activate Murine Bone Marrow‐Derived Mast Cells. Genes to Cells. https://doi.org/10.1111/gtc.70047

Vancouver

Inoue H, Sakakibara H, Kamada S, Ogata A, Hayashi K, Hida S, et al. Staphylococcal γ‐Hemolysin AB and γ‐Hemolysin CB Differentially Activate Murine Bone Marrow‐Derived Mast Cells. Genes to Cells. 2025. doi:10.1111/gtc.70047

BibTeX
@article{Inoue2025,
  author = {Inoue, Hikaru and Sakakibara, Haruka and Kamada, Shion and Ogata, Ayana and Hayashi, Kazuhito and Hida, Shigeaki and Itoh, Saotomo},
  title = {Staphylococcal γ‐Hemolysin AB and γ‐Hemolysin CB Differentially Activate Murine Bone Marrow‐Derived Mast Cells},
  journal = {Genes to Cells},
  year = {2025},
  doi = {10.1111/gtc.70047}
}
Kostenlos starten →